Abnormal Expression of Microtubule-Associated Protein 2 (MAP-2) in Neocortex in Rett Syndrome
The DOI matches its Crossref record.
Abstract
Immunocytochemical evaluations of the neocortex of three classical Rett syndrome (RS) individuals revealed a selective abnormality in the expression of microtubule-associated protein 2 (MAP-2). MAP-2 immunoreactivity (ir) was reduced throughout the neocortex of all three RS cases with a reversal of the normal pattern of more intense staining in deep cortical layers. This anomaly was selective for MAP-2 because nonphosphorylated neurofilament (SMI-32) labeling of deep pyramidal neurons and calbindin (CaBP)-stained GABAergic cells remained unchanged. Moreover, MAP-2 ir was virtually undetected in white matter while GABAergic and, particularly, peptidergic (neuropeptide Y: NPY) profiles were easily recognized. These results demonstrate a marked disruption of a major cytoskeletal component in neocortex in RS which seems to affect, predominantly, pyramidal projection and white matter neurons. MAP-2 expression appears early in neuronal maturation of the neocortex, particularly in the subplate region, the future superficial white matter, suggesting that these reported abnormalities in RS represent a developmental disturbance. Considering that MAP-2 expression is regulated by several neurotransmitter systems in adult cerebral cortex, particularly dopaminergic and cholinergic afferents that are deficient in RS, these neurochemical alterations could be related to this anomalous MAP-2 expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Dendritic Anomalies in Disorders Associated with Mental Retardation
Kaufmann, W. E. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.10.981 · Cited by 731
Self-citationThe dendritic tree and brain disorders
Kulkarni, V. A., & Firestein, B. L. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.03.005 · Cited by 390
Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome
Asaka, Y., Jugloff, D. G. M., Zhang, L., Eubanks, J. H., & Fitzsimonds, R. M. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.07.005 · Cited by 341
Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized
Bienvenu, T., & Chelly, J. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1878 · Cited by 289
Neuropathology of Rett Syndrome
Duncan Armstrong, D. (2005) · Journal of Child Neurology · doi:10.1177/08830738050200090901 · Cited by 281
Characterisation of breathing and associated central autonomic dysfunction in the Rett disorder
Julu, P. O. O., Kerr, A. M., Apartopoulos, F., Al-Rawas, S., Engerström, I. W., Engerström, L., Jamal, G. A., & Hansen, S. (2001) · Archives of Disease in Childhood · doi:10.1136/adc.85.1.29 · Cited by 277
Dendritic spines: Revisiting the physiological role
Chidambaram, S. B., Rathipriya, A. G., Bolla, S. R., Bhat, A., Ray, B., Mahalakshmi, A. M., Manivasagam, T., Thenmozhi, A. J., Essa, M. M., Guillemin, G. J., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.01.005 · Cited by 255
Chapleau, C. A., Calfa, G. D., Lane, M. C., Albertson, A. J., Larimore, J. L., Kudo, S., Armstrong, D. L., Percy, A. K., & Pozzo-Miller, L. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.05.001 · Cited by 252
Preclinical research in Rett syndrome: setting the foundation for translational success
Katz, D. M., Berger-Sweeney, J. E., Eubanks, J. H., Justice, M. J., Neul, J. L., Pozzo-Miller, L., Blue, M. E., Christian, D., Crawley, J. N., Giustetto, M., et al. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.011007 · Cited by 206
More than a marker: potential pathogenic functions of MAP2
DeGiosio, R. A., Grubisha, M. J., MacDonald, M. L., McKinney, B. C., Camacho, C. J., & Sweet, R. A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.974890 · Cited by 162
“In several case reports of intellectual disability and autism, reduced numbers of MAP2-IR+ neurons and dendrites has been noted, without a change in total neuron number (Kaufmann et al., 1995; Mukaetova-Ladinska et al., 2004).”
BackgroundGupta, N., Ly, T., Zhang, Q., Kaufman, P. L., Weinreb, R. N., & Yücel, Y. H. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2006.09.013 · Cited by 122
Cohen, D. R. S., Matarazzo, V., Palmer, A. M., Tu, Y., Jeon, O. K.-H., Pevsner, J., & Ronnett, G. V. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00026-5 · Cited by 119
Rietveld, L., Stuss, D. P., McPhee, D., & Delaney, K. R. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00145 · Cited by 39
“Given that soma size has been reported to correlate with dendritic complexity (Kaufmann et al., 1995), these data may support a model in which MeCP2− neurons find it difficult to compete for connections in female brains with a highly skewed XCI ratio where the MeCP2+ neurons predominate.”
ResultQuantitative 1 H MR spectroscopic imaging in early Rett syndrome
Horská, A., Naidu, S., Herskovits, E. H., Wang, P. Y., Kaufmann, W. E., & Barker, P. B. (2000) · Neurology · doi:10.1212/wnl.54.3.715 · Cited by 38
Self-citation
Metadata
- Authors
- Kaufmann, W., Naidu, S., & Budden, S.
- Venue
- Neuropediatrics
- Publisher
- Georg Thieme Verlag KG
- Published
- 1995-04
- Volume
- 26
- Issue
- 02
- Pages
- 109-113
- ISSN
- 0174-304X (ISSN-L)
- 1439-1899
- OpenAlex
- W2023206952
- Cited by
- 77
- References
- 0
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.